-
Mashup Score: 0The BSH Guidelines Official Podcast - 2 year(s) ago
Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases. Self accreditation Listen to two podcasts and …
Source: podcasts.b-s-h.org.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The BSH Guidelines Official Podcast - 2 year(s) ago
Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases. Self accreditation Listen to two podcasts and …
Source: podcasts.b-s-h.org.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1The BSH Guidelines Official Podcast - 2 year(s) ago
Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases. Self accreditation Listen to two podcasts and …
Source: podcasts.b-s-h.org.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0How novel agents are transforming the treatment landscape of SCD - 2 year(s) ago
Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, shares some insights into the current…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The treatment and management of PTLD - 2 year(s) ago
In this video, Sridhar Chaganti, MD, PhD, MRCP, FRCPath, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, discusses the management…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Novel treatment agents and how they’re changing the MPN field - 2 year(s) ago
Claire Harrison, MD, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses novel treatment approaches in myeloproliferative…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3How targeted therapies are sequenced in CLL - 2 year(s) ago
Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, briefly discusses the sequencing of targeted therapies in chronic lymphocytic leukemia (CLL)….
Source: VJHemOncCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @VJHemOnc: Barbara Eichhorst (@UKKoeln) discusses the sequencing of targeted therapies in CLL: 🎥: https://t.co/Txo1SvH8FC @BritSocHa…
-
-
Mashup Score: 0
In this video, Kate Cwynarski, FRCP, FCRPath, PhD, University College London Hospitals NHS Foundation Trust, London, UK, and Andrew Davies,…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, gives an overview of recent…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0An insight into the role of the Sickle Cell Society - 2 year(s) ago
In this video, John James, OBE, Sickle Cell Society, London, UK, discusses sickle cell disease (SCD) and its impact on…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
ICYMI: We have uploaded five new podcasts to our BSH guidelines channel this June Dive into our ASM series - guidelines which featured as part of #BSH2022 programme https://t.co/aEUijnoR60 https://t.co/NsJaApP0lG